AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.069

-0.003-4.17%

Volume:66.34K

Turnover:4.61K

Market Cap:25.25M

PE:-2.71

High:0.071

Open:0.070

Low:0.069

Close:0.072

Loading ...

Overview Company News Filings

Bcal Diagnostics Expands Access to Breast Cancer Test to Three Clinics in Sydney, Melbourne; Shares Up 4%

MT Newswires Live

Equity Markets Higher as US Weekly Jobless Claims Rise

MT Newswires Live

Sector Update: Health Care Stocks Mixed Premarket Thursday

MT Newswires Live

Becton, Dickinson and Co Launches Umbilical Hernia Patch After FDA Clearance

MT Newswires Live

BCAL Diagnostics' BREASTEST Plus to Generate First Sales

MT Newswires Live

BCAL Diagnostics launches groundbreaking blood test to aid early detection of breast cancer

Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial

MT Newswires Live

BRIEF-Bcal Diagnostics Posts HY Net Loss Attributable A$4 Mln

BCAL Diagnostics - Hy Net Loss Attributable a$4 Mln

THOMSON REUTERS

When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit?

Simply Wall St.

Sector Update: Health Care Stocks Higher Monday Afternoon

MT Newswires Live

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT Newswires Live

When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit?

Simply Wall St.

Becton, Dickinson Plans More Investments in US to Add Critical Medical Device Capacity

MT Newswires Live

These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More

Sector Update: Health Care Stocks Advance Premarket Thursday

MT Newswires Live

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of FOMC Meeting Announcement

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BDX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.069,"timestamp":1749190320000,"preClose":0.072,"halted":0,"volume":66342,"delay":0,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":365967890,"eps":-0.025462,"marketStatus":"Closed King Birthday Day","change":-0.003,"latestTime":"06-06 16:12:00 AEST","open":0.07,"high":0.071,"low":0.069,"amount":4612,"amplitude":0.027778,"askPrice":0.074,"askSize":12615,"bidPrice":0.063,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":-0.025462,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.072,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":1.9540859537887532,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-48.05%","roe":"-104.23%","lyrEps":-0.025993,"volumeRatio":1.9540859537887532,"shares":365967890,"dividePrice":0,"high":0.071,"amplitude":0.027778,"preClose":0.072,"low":0.069,"week52Low":0.069,"pbRate":"2.72","psRate":"9.63","week52High":0.175,"institutionHeld":0,"latestPrice":0.069,"committee":0.22643,"eps":-0.025462,"divideRate":0,"volume":66342,"delay":0,"ttmEps":-0.025462,"open":0.07,"prevYearClose":0.097,"prevWeekClose":0.075,"prevMonthClose":0.075,"prevQuarterClose":0.102,"fiveDayClose":0.075,"twentyDayClose":0.075,"sixtyDayClose":0.096},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533351755","title":"Bcal Diagnostics Expands Access to Breast Cancer Test to Three Clinics in Sydney, Melbourne; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533351755","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533351755?lang=en_us&edition=fundamental","pubTime":"2025-05-06 11:41","pubTimestamp":1746502892,"startTime":"0","endTime":"0","summary":"Bcal Diagnostics  expanded access to Breastest plus to three specialist breast clinics across Sydney and Melbourne, according to a Tuesday filing with the Australian bourse.The blood test, which is used to rule out the presence of breast cancer in women with high breast density, will be available at the additional clinics starting mid-May, the filing stated.Bcal Diagnostics' shares were up nearly 4% in recent Tuesday trade.Price : $0.08, Change: $+0.0030, Percent Change: +3.85%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK6100","NPL.SI","BK7067","BDX.AU"],"gpt_icon":0},{"id":"2532882290","title":"Equity Markets Higher as US Weekly Jobless Claims Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2532882290","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532882290?lang=en_us&edition=fundamental","pubTime":"2025-05-02 03:50","pubTimestamp":1746129047,"startTime":"0","endTime":"0","summary":"US benchmark equity indexes are on track to close higher on Thursday, after US weekly jobless claims jumped to the highest level since the week ended Feb. 22.The Dow Jones Industrial Average gained 0.7% to 40,940.86, while the Nasdaq Composite increased 2.2% to 17,829.99. The S&P 500 was up 1.2% to 5,637.26. Technology and communication sectors were the top gainers, while healthcare saw the steepest decline.Carrier Global  shares were up nearly 12%, the top performer on the S&P 500. The company reported first quarter adjusted earnings and sales, beating analysts' estimates and raised its 2025 guidance.Microsoft  shares jumped 8.8%, the top gainer on the Dow and among the best on the S&P 500. The tech giant posted stronger-than-expected fiscal third-quarter results late Wednesday as demand for its cloud offerings grew.Becton, Dickinson  shares fell 16%, the worst performer on the S&P 500. The company's fiscal second quarter revenue fell short of Wall Street's estimates, and it lowered f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"72516cdbe87c6f953cf02d4701b64a5e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2506952170.USD","UDOW","LU1868837136.USD","DJX","BDX.AU","VOO","USAW.SI","DXD","LU0310800379.SGD","SPY","USJW.SI","BDX","OEF",".DJI","LU1153585028.USD","PSQ","ESmain","SH","DDM","QLD","SQQQ","IVV","NQmain","LU1564329032.USD","EQR","OEX","MSFT","QID","DOG","TQQQ","LU1582987324.SGD","GB00B4LPDJ14.GBP","SPXU","SG9999014914.USD",".SPX","BK4585","SSO","LU2023250843.SGD",".IXIC","CARR","SDS","NVIW.SI","TSYW.SI","LU0965509010.AUD","MNQmain","SDOW","LU0347712357.USD","LU1496350171.SGD"],"gpt_icon":1},{"id":"2532077427","title":"Sector Update: Health Care Stocks Mixed Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2532077427","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532077427?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:11","pubTimestamp":1746105079,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Thursday as the Health Care Select Sector SPDR Fund  was down 0.6% and the iShares Biotechnology ETF  was up 0.1% recently.Eli Lilly  shares declined nearly 5% after the company cut its 2025 adjusted earnings per share guidance.CVS Health  shares rose past 8% after the company reported higher Q1 adjusted earnings and revenue and raised its 2025 adjusted EPS outlook.Becton, Dickinson  shares declined nearly 6% after the company lowered its 2025 adjusted earnings per share forecast.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","LU0266013472.USD","LU2471134952.CNY","SGXZ81514606.USD","IE00B4R5TH58.HKD","LU0096364046.USD","LU1548497426.USD","LU0985320562.USD","LU0006061336.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","IE00B2B36J28.USD","LU0070302665.USD","IE00BJLML261.HKD","LU2471134879.HKD","IE00BK4W5M84.HKD","LU2237443465.HKD","LU1983299246.USD","CVS","LU0256863811.USD","LU2361044949.HKD","LU2471134796.USD","SG9999001176.SGD","IE0009355771.USD","BDX.AU","LU0456855351.SGD","IBB","SG9999015978.USD","IE00BK4W5L77.USD","BK4588","LU2360106947.USD","BK4585","SG9999014906.USD","LU0511384066.AUD","LU2361044865.SGD","BK4082","BDX","BK4550","LU0289961442.SGD","LU0385154629.USD","LU1988902786.USD","LU0882574055.USD","BK4504","LU2471134523.USD","LU1150488218.USD","SG9999013999.USD","LU1804176565.USD","CVS.AU"],"gpt_icon":1},{"id":"2529050711","title":"Becton, Dickinson and Co Launches Umbilical Hernia Patch After FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2529050711","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529050711?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:26","pubTimestamp":1745411211,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Co  said Wednesday it is launching its Phasix ST umbilical hernia patch after receiving 510 clearance from the US Food and Drug Administration.The product is designed to duplicate the form, function and technique of the Ventralex ST hernia patch, which has more than 2 million implants globally, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","LU0289739343.SGD","LU0985489474.SGD","LU1894683348.USD","LU1150488135.SGD","LU0878866978.SGD","LU0433182093.SGD","BDX","BK4588","LU1059921491.USD","LU1571399168.USD","LU1854104046.USD","LU0289961442.SGD","LU1489326972.SGD","LU1854103824.USD","LU0985320562.USD","BDX.AU","LU1150488218.USD","BK4585","BK4504","LU0511384066.AUD","LU1894683264.USD","LU0068578508.USD","BK4082","BK7067","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2521765148","title":"BCAL Diagnostics' BREASTEST Plus to Generate First Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2521765148","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521765148?lang=en_us&edition=fundamental","pubTime":"2025-03-24 14:39","pubTimestamp":1742798377,"startTime":"0","endTime":"0","summary":"BCAL Diagnostics  said its breast cancer diagnostic product, BREASTEST Plus will generate its first sales revenue this week, according to a Monday Australian bourse filing.The company said it has been granted a diagnostic signature patent by IP Australia providing the diagnostic blood test kit intellectual property protection till 2043.The company's shares jumped 17% on market close.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCAL","BDX.AU"],"gpt_icon":0},{"id":"2521585417","title":"BCAL Diagnostics launches groundbreaking blood test to aid early detection of breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2521585417","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521585417?lang=en_us&edition=fundamental","pubTime":"2025-03-24 10:46","pubTimestamp":1742784377,"startTime":"0","endTime":"0","summary":"BCAL Diagnostics  has launched a first-in-class blood test known as BREASTEST plus to address the challenge of high breast density, which can impact standard-of-care breast cancer screening practices.The company designed the lipid test for use alongside traditional mammogram imaging and it has been validated to meet the challenge of high breast density, which affects approximately 50% of Australian women participating in breast cancer screening programs.The new test will be available at Sydney Breast Clinic from 27 March, followed by a planned rollout to select clinical sites nationwide starting with Sydney and Melbourne.“The commercial launch of BREASTEST plus is an incredible milestone for us and for the future of breast cancer screening,” he said.“Anything we can do to detect breast cancer earlier, to rule it in or out, is a vital step forward for women and saving more lives,” he said.Mr Ryan said BCAL also retained exclusive global rights to intellectual property related to the app","market":"us","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/BCAL-Diagnostics-ASX-BDX-Launches-BREASTEST-plus.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/BCAL-Diagnostics-ASX-BDX-Launches-BREASTEST-plus.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/bcal-diagnostics-launches-blood-test-early-detection-breast-cancer/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XJO.AU","BK4211","BK7067","BDX.AU","XKO.AU","XAO.AU","BCAL"],"gpt_icon":0},{"id":"2520453350","title":"Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2520453350","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520453350?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:50","pubTimestamp":1742471442,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Thursday that the first patient had been treated in its clinical trial for the use of GalaFlex Lite Scaffold to decrease capsular contracture recurrence during breast revision surgery.Patient enrollment continues for the trial, which will evaluate whether GalaFlex Lite Scaffold will reduce the likelihood of capsular contracture and/or malposition in breast revision surgery, according to the company.Becton, Dickinson said it expects to enroll at least 250 patients across 40 sites for the trial.The company said the trial is intended to advance the product candidate towards premarket approval from the US Food and Drug Administration.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX","LU0068578508.USD","LU0878866978.SGD","BK7067","BDX.AU","IE00BFXG1179.USD","LU1150488218.USD","LU0433182093.SGD","BK4082","LU0266013472.USD","LU0985320562.USD","LU0289961442.SGD","LU1894683348.USD","LU1059921491.USD","LU0985489474.SGD","LU1854104046.USD","LU0511384066.AUD","BK4585","LU1150488135.SGD","LU0289739343.SGD","BK4588","LU1894683264.USD","LU1489326972.SGD","LU1571399168.USD","LU1854103824.USD","BK4504"],"gpt_icon":0},{"id":"2514036576","title":"BRIEF-Bcal Diagnostics Posts HY Net Loss Attributable A$4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514036576","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514036576?lang=en_us&edition=fundamental","pubTime":"2025-02-28 09:32","pubTimestamp":1740706321,"startTime":"0","endTime":"0","summary":"BRIEF-Bcal Diagnostics Posts HY Net Loss Attributable A$4 MlnFeb 28 (Reuters) - BCAL Diagnostics Ltd BDX.AX:HY NET LOSS ATTRIBUTABLE A$4 MILLIONFurther company coverage: BDX.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PI29B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"gpt_icon":0},{"id":"2514563203","title":"BCAL Diagnostics - Hy Net Loss Attributable a$4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514563203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514563203?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:08","pubTimestamp":1740694104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI29B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"gpt_icon":0},{"id":"2510073682","title":"When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510073682","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510073682?lang=en_us&edition=fundamental","pubTime":"2025-02-10 07:08","pubTimestamp":1739142517,"startTime":"0","endTime":"0","summary":"BCAL Diagnostics Limited  is possibly approaching a major achievement in its business, so we would like to shine some light on the company. BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. The AU$37m market-cap company announced a latest loss of AU$6.4m on 30 June 2024 for its most recent financial year result. As path to profitability is the topic on BCAL Diagnostics' investors mind, we've decided to gauge market sentiment. In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.BCAL Diagnostics is bordering on breakeven, according to some Australian Biotechs analysts. They anticipate the company to incur a final loss in 2025, before generating positive profits of AU$3.8m in 2026. Therefore, the company is expected to breakeven just over a year from now. How fast will the company have to grow each","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bcal-diagnostics-limited-asx-bdx-230837644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IE00BFXG1179.USD","BK7067","LU1854104046.USD","BK4082","BK4504","BK4588","LU0289739343.SGD","LU1571399168.USD","LU1059921491.USD","LU0985320562.USD","BCAL","BDX.AU","LU1894683264.USD","LU0266013472.USD","BK4585","BDX","LU0289961442.SGD","LU1894683348.USD","LU0511384066.AUD","BK4211","LU1854103824.USD"],"gpt_icon":0},{"id":"2508124561","title":"Sector Update: Health Care Stocks Higher Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2508124561","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508124561?lang=en_us&edition=fundamental","pubTime":"2025-02-04 03:03","pubTimestamp":1738609380,"startTime":"0","endTime":"0","summary":"Health care stocks were higher Monday afternoon, with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund  adding 0.6%.The iShares Biotechnology ETF  shed 0.3%.In corporate news, IDEXX Laboratories  shares jumped 12% after the company reported quarterly earnings that beat estimates.Becton Dickinson  is considering a potential separation of its life science division, according to media reports. Becton Dickinson shares were up 0.6%.Annovis Bio  shares fell nearly 30%. The company said it priced an underwritten public offering of 5.25 million shares and warrants to buy 5.25 million shares at a combined price of $4 per share.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","BDX.AU","GB00B4QBRK32.GBP","BK4581","LU0266013472.USD","BK4082","LU1854104046.USD","LU2404859741.USD","XLV","LU1941712264.USD","LU0289961442.SGD","LU1059921491.USD","BK4585","LU1989771016.USD","LU1291159041.SGD","BK4588","LU1941712348.USD","BK4139","LU0511384066.AUD","LU0289739343.SGD","LU1571399168.USD","BK4504","LU0690374961.EUR","LU1894683264.USD","IBB","LU0690374615.EUR","BK4567","IDXX","GB00B4LPDJ14.GBP","LU1854103824.USD","LU1894683348.USD","BK7067","LU0170899867.USD","BDX","LU2404859667.USD","ANVS"],"gpt_icon":0},{"id":"2508145474","title":"Sector Update: Health Care Stocks Lean Lower Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2508145474","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508145474?lang=en_us&edition=fundamental","pubTime":"2025-02-03 22:08","pubTimestamp":1738591726,"startTime":"0","endTime":"0","summary":"Health care stocks leaned lower premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was down 0.5% and the iShares Biotechnology ETF (IBB) declined by 1.6% recently.Owens & Minor (OMI) sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","BK4175","LU1894683348.USD","BK4539","GHRS","BK4504","LU1894683264.USD","BK4581","BDX.AU","BK4082","LU0289961442.SGD","XLV","BK4007","BK4585","BK7067","LU1059921491.USD","LU0289739343.SGD","OMI","LU0511384066.AUD","BK4588","LU0266013472.USD","LU1854103824.USD","LU1854104046.USD","BDX","IBB","LU1571399168.USD"],"gpt_icon":0},{"id":"2508162639","title":"When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit?","url":"https://stock-news.laohu8.com/highlight/detail?id=2508162639","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508162639?lang=en_us&edition=fundamental","pubTime":"2025-02-01 04:14","pubTimestamp":1738354492,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at BCAL Diagnostics...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-bdx/bcal-diagnostics-shares/news/when-will-bcal-diagnostics-limited-asxbdx-turn-a-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854103824.USD","IE00BFXG1179.USD","LU1571399168.USD","BK4585","LU0511384066.AUD","LU0289961442.SGD","BK4588","BK7067","LU0289739343.SGD","BK4082","BCAL","LU1894683264.USD","BDX.AU","LU1894683348.USD","BDX","LU1854104046.USD","LU0266013472.USD","BK4211","LU1059921491.USD","BK4504"],"gpt_icon":0},{"id":"2503626872","title":"Becton, Dickinson Plans More Investments in US to Add Critical Medical Device Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2503626872","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503626872?lang=en_us&edition=fundamental","pubTime":"2025-01-15 23:44","pubTimestamp":1736955842,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Co.  said Wednesday it plans to increase capacity for critical medical devices by making new investments in its manufacturing facilities in the US.The company intends to invest more than $30 million this year to increase manufacturing capacity for IV lines at its Utah plant.Becton, Dickinson said it installed new needle and syringe production lines at its plants in Connecticut and Nebraska as part of its 2024 investment of more than $10 million. One line is now fully operational, while additional lines are likely to start up in the coming months, the company said.Price: 235.45, Change: -0.35, Percent Change: -0.15","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","BDX","BK4082","BK4588","LU0289961442.SGD","BK7067","LU0266013472.USD","BDX.AU","LU0289739343.SGD","LU0511384066.AUD","LU1059921491.USD","LU1854103824.USD","LU1854104046.USD","BK4585","LU1571399168.USD","BK4504"],"gpt_icon":0},{"id":"2489268381","title":"These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More","url":"https://stock-news.laohu8.com/highlight/detail?id=2489268381","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489268381?lang=en_us&edition=fundamental","pubTime":"2024-12-07 02:34","pubTimestamp":1733510088,"startTime":"0","endTime":"0","summary":"Hormel and Campbell’s are two companies that increased their dividend payouts to shareholders this week.If you’re looking to invest in companies known for paying out dividends consistently over time, like PepsiCo, Becton Dickinson, H.B. Fuller, PPG Industries, and Tennant Co., stock screeners and online brokers offer helpful tools for identifying these opportunities.Stocks known as “dividend kings” have longstanding histories of steady dividend payments that can help keep returns above water in turbulent markets.Fortunately, there are stocks—such as the so-called “Dividend Kings”—that have longstanding histories of steady dividend payments. Those dividends can keep many stocks’ returns above water even when the rest of the market is at risk for drowning.Top Stocks With 50 Years of Dividend Growth History Right Now. Ben Reynolds, founder and CEO of SureDividend.com, which publishes a list of Dividend Kings, goes one step further in the hunt for good dividend growers. He suggests seeking","market":"sg","thumbnail":"https://www.investopedia.com/thmb/YqO-lCW0zpQIen39Ahvb-hofXx4=/5070x3380/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1363105622-db8a41ae93114d798d287081360d52e8.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/YqO-lCW0zpQIen39Ahvb-hofXx4=/5070x3380/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1363105622-db8a41ae93114d798d287081360d52e8.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/these-5-stocks-have-50-years-of-dividend-growth-here-is-how-to-find-more-8756708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["FUL","LU1929549753.HKD","LU0320765646.SGD","LU0266013472.USD","BK4534","LU0289739343.SGD","BDX","LU1854103824.USD","IE00B3T34201.USD","BK4550","LU1162221912.USD","BK7095","PEP","TNC","TNC.AU","IE00BFXG1179.USD","BK4581","LU0234572021.USD","US10Y.BOND","LU1244550221.USD","BK4533","US2Y.BOND","BK4082","FUL.AU","LU1244550577.SGD","BK4177","US30Y.BOND","LU1244550494.USD","BK4585","LU0289961442.SGD","BK4161","BK4566","BK7067","LU1059921491.USD","BDX.AU","BK4109","PPG","PPG.AU","US5Y.BOND","US7Y.BOND","LU1571399168.USD","BK4588","LU0098860793.USD","US3Y.BOND","LU1854104046.USD","US6M.BOND","BK7063","US12M.BOND","BK4504","LU1894683264.USD"],"gpt_icon":0},{"id":"2481137617","title":"Sector Update: Health Care Stocks Advance Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2481137617","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481137617?lang=en_us&edition=fundamental","pubTime":"2024-11-07 22:12","pubTimestamp":1730988733,"startTime":"0","endTime":"0","summary":"Health care stocks were advancing in premarket activity Thursday, with the iShares Biotechnology ETF  0.4% higher and the Health Care Select Sector SPDR Fund  up 0.3% recently.Moderna  shares were up more than 7% after the company reported a swing to Q3 earnings as revenue increased during the period.Dentsply Sirona  shares fell past 11% after the company lowered its outlook for full-year adjusted earnings per share and revenue.Becton, Dickinson  shares advanced by over 1% after the company reported higher fiscal Q4 adjusted earnings and revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX","IBB","BK4533","BK4534","LU1854104046.USD","LU0511384066.AUD","BK4551","LU1854103824.USD","XLV","BK4585","BK4581","BK4501","LU1571399168.USD","LU0289961442.SGD","BK4504","LU1059921491.USD","BK4139","BK4568","BK4588","BK7067","LU0266013472.USD","LU0289739343.SGD","BK4532","IE00BFXG1179.USD","BK4198","BK4082","BDX.AU","XRAY","BK4548","MRNA"],"gpt_icon":1},{"id":"2481375961","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of FOMC Meeting Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2481375961","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481375961?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:26","pubTimestamp":1730985970,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Thursday's premarket activity, ahead of the Federal Op","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPK","US12M.BOND","US5Y.BOND","BITO","IGM",".SPX","IGV","SOXX","WOLF","XLE","QQQ","SLV","US10Y.BOND",".DJI","IYE","IYJ","VHT.AU","XLP","BDX","USO","XLI","VIS","FAS","ROK","IYH","EPAM","SPY.AU","IVV","IYW","MUR","US30Y.BOND","US3Y.BOND","US6M.BOND","RTH","US7Y.BOND","BDX.AU","FAZ","US2Y.BOND","UNG","XLY","VDC","VHT","XSD","COTY","FDN","FOMC","GLD","XLV","EQR","EEM","RTH.AU"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[]}}